The Controversy That Sparked Confusion
Much of the recent debate was ignited by the World Health Organization (WHO), which advised against using non-sugar sweeteners (NSS) for long-term weight control. This announcement led to headlines that sounded like a total condemnation. However, the WHO's
own review noted that this was a "conditional recommendation." The report highlighted that while randomized trials showed some short-term weight loss when sweeteners replaced sugar, long-term observational studies found potential links to an increased risk of type 2 diabetes and cardiovascular diseases. This conflict between different types of studies is the very heart of the confusion.
Understanding the Evidence
It's crucial to distinguish between different types of scientific evidence. Many of the studies raising alarms are observational, meaning they identify correlations but cannot prove causation. For example, people who are already at a higher risk for health issues might be more likely to use sweeteners, creating a link that isn't the fault of the sweetener itself. The WHO acknowledged this possibility, known as "reverse causation." Meanwhile, regulatory bodies like the U.S. Food and Drug Administration (FDA) have reviewed the evidence, including on controversial sweeteners like aspartame, and continue to deem them safe for the general population when consumed within established limits. The FDA noted "significant shortcomings" in the studies that led the WHO's cancer agency to classify aspartame as "possibly carcinogenic."
Portion Size Is Everything
This brings us to the first key word in the headline: portion. Every approved sweetener has an Acceptable Daily Intake (ADI), which is the maximum amount considered safe to consume every day over a lifetime. These limits are set with extreme caution, often 100 times less than the amount found to cause no adverse effects in studies. For example, the ADI for aspartame is 50 mg per kg of body weight. For a 70 kg adult, that’s equivalent to drinking roughly 9 to 14 cans of diet soda every single day. For sucralose, you'd need to consume more than 85 single-serving packets to reach the ADI. Most people's consumption doesn't even come close to these levels.
Context Determines the Benefit
The second key word is context. The health impact of a sweetener depends entirely on what it is replacing. Swapping a daily sugary beverage for a diet version can be a helpful short-term strategy to reduce calorie and sugar intake. However, simply adding sweeteners to an already healthy diet provides no nutritional value. The ultimate goal, as many experts suggest, should be to reduce our overall reliance on intense sweetness, whether from sugar or substitutes. Thinking of sweeteners as a free pass to indulge elsewhere—the "I had a diet drink, so I can have this cake" mindset—negates any potential benefit.
The Indian Perspective
In India, the Food Safety and Standards Authority of India (FSSAI) regulates the use of sweeteners. It has approved several, including aspartame, sucralose, and steviol glycosides, establishing specific limits for their use in different food products. Following the WHO's announcements, FSSAI officials clarified that India would rely on its own risk assessments to set standards for the Indian population, rather than simply adopting international guidelines without local context. FSSAI also mandates clear labelling, for example, requiring a warning for people with phenylketonuria (PKU), a rare genetic condition, on products containing aspartame.
